CTOR: Citius Oncology, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Armistice Capital, LLC | 9.99% | SEC |
Institutional ownership (Q2 2026)
19 institutions reported holding $9.18M of Citius Oncology, Inc. on Form 13F (14 the quarter before). 7 opened a new position and 2 sold out. Shares held by institutions: -1%.
| Largest holders | Shares | Value |
|---|---|---|
| ARMISTICE CAPITAL, LLC | 8,705,589 | $5.66M |
| BANK OF AMERICA CORP /DE/ | 3,835,160 | $2.49M |
| VANGUARD CAPITAL MANAGEMENT LLC | 546,325 | $355K |
| UBS Group AG | 334,619 | $218K |
| GEODE CAPITAL MANAGEMENT, LLC | 245,407 | $160K |
| VANGUARD FIDUCIARY TRUST CO | 121,910 | $79K |
| IFP Advisors, Inc | 107,424 | $70K |
| CITADEL ADVISORS LLC | 90,586 | $59K |
| NORTHERN TRUST CORP | 45,746 | $30K |
| STATE STREET CORP | 42,900 | $28K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.